Back to search
Thyroid Gland Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Thyroid Gland Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Thyroid Gland Disease trials you may qualify forThis is a study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antit…
This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adu…
The purpose of this study is to better understand the outcomes of active surveillance (observation) instead of immediate surgery, which is the current standard…
Study rationale High risk patients with differentiated thyroid cancer (DTC) require therapy with 131 I under thyroid stimulating hormone (TSH) stimulation. The…
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
The investigators have previously proposed a prediction model for difficult transoral and submental thyroidectomy through a retrospective study. In order to bet…
This is a long-term extension study that will rollover participants completing feeder studies IMVT-1402-2502 (NCT06727604) or IMVT-1402-2503 (NCT07018323) to ev…
Background: Oncocytic (Hurthle cell) thyroid cancer (HTC) is a rare disease with few treatment options. Researchers are developing a radioactive drug that targ…